InMed Pharmaceuticals Inc. - Common Shares, no par value (INM)
CUSIP: 457637601
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 804,525
- Total 13F shares
- 115,828
- Share change
- -17,165
- Total reported value
- $234,169
- Price per share
- $2.00
- Number of holders
- 11
- Value change
- -$203,650
- Number of buys
- 8
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 457637601?
CUSIP 457637601 identifies INM - InMed Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 457637601:
Top shareholders of INM - InMed Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
11%
|
90,000
|
$593,000 | — | 30 Sep 2022 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
15,284
|
$101,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.7%
|
13,922
|
$91,000 | — | 30 Sep 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.84%
|
6,770
|
$45,000 | — | 30 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0.72%
|
5,797
|
$38,000 | — | 30 Sep 2022 | |
| Bruce Colwill |
3/4/5
|
CFO |
—
class O/S missing
|
11,515
|
$10,294 | — | 24 Jan 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.13%
|
1,067
|
$7,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
134
|
$1,000 | — | 30 Sep 2022 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0.01%
|
85
|
$757 | — | 30 Sep 2022 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
19
|
$125 | — | 30 Sep 2022 | |
| Catherine Sazdanoff |
3/4/5
|
Director |
—
class O/S missing
|
29,091
|
— | — | 29 Dec 2021 | |
| Adam D. Cutler |
3/4/5
|
Director |
—
class O/S missing
|
16,122
|
— | — | 24 Jan 2022 | |
| Mr. William J. Garner |
3/4/5
|
Director |
—
class O/S missing
|
16,122
|
— | — | 24 Jan 2022 | |
| Ms. Sarah Li |
3/4/5
|
VP Accounting & Controller |
—
class O/S missing
|
4,002
|
— | — | 16 Dec 2022 |
Institutional Holders of InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) as of Q4 2022
As of 31 Dec 2022,
InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
115,828 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Virtu Financial LLC, UBS Group AG, BlackRock Inc., AllSquare Wealth Management LLC, Federation des caisses Desjardins du Quebec, NATIONAL BANK OF CANADA /FI/, Advisory Services Network, LLC, TCI Wealth Advisors, Inc., and MORGAN STANLEY.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
8
Q4 2022 holders
11
Holder diff
3
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.